|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61M 16/00 | (2006.01) |
| G01F 22/02 | (2013.01) | ||
| A61M 16/12 | (2006.01) | ||
| A61M2016/0027 | (2013.01) | ||
| B63C 11/02 | (2006.01) | ||
| A61M2016/0039 | (2013.01) | ||
| G01F 22/02 | (2006.01) | ||
| A61M2202/0275 | (2013.01) | ||
| A61M 16/20 | (2006.01) | ||
| A61M2205/14 | (2013.01) | ||
| A61M 15/00 | (2006.01) | ||
| A61M2205/16 | (2013.01) | ||
| A61M2205/17 | (2013.01) | ||
| A61M2205/3331 | (2013.01) | ||
| A61M2205/3368 | (2013.01) | ||
| A61M2205/50 | (2013.01) | ||
| A61M2205/502 | (2013.01) | ||
| A61M2205/60 | (2013.01) | ||
| A61M2205/8206 | (2013.01) | ||
| A61M 16/204 | (2014.02) | ||
| A61M2205/6018 | (2013.01) | ||
| B63C 11/02 | (2013.01) | ||
| F17C2250/00 | (2013.01) | ||
| A61M 16/024 | (2017.08) | ||
| A61M2205/52 | (2013.01) | ||
| A61M 16/208 | (2013.01) | ||
| A61M2205/6072 | (2013.01) | ||
| A61M 16/085 | (2014.02) | ||
| A61M2016/102 | (2013.01) | ||
| A61M 16/0051 | (2013.01) | ||
| A61M 16/125 | (2014.02) | ||
| A61M2205/3334 | (2013.01) |
| (11) | Number of the document | 3581226 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19168698.9 |
| Date of filing the European patent application | 2015-05-11 | |
| (97) | Date of publication of the European application | 2019-12-18 |
| (45) | Date of publication and mention of the grant of the patent | 2024-02-28 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201461991083 P | 2014-05-09 | US | |
| 201461991028 P | 2014-05-09 | US | |
| 201461991032 P | 2014-05-09 | US |
| (72) |
ACKER, Jaron M. , US
FALLIGANT, John C. , US
MILSAP, Jeff , US
ROEHL, Robin , US
SCHMIDT, Jeffrey , US
TOLMIE, Craig R. , US
|
| (73) |
Mallinckrodt Pharmaceuticals Ireland Limited ,
College Business & Technology Park
Cruiserath, Blanchardstown, Dublin 15,
IE
|
| (54) | SYSTEMS FOR DELIVERY OF THERAPEUTIC GAS |
| SYSTEMS FOR DELIVERY OF THERAPEUTIC GAS |